The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma
Abstract: Localized renal cell carcinoma is primarily managed surgically, but this disease commonly presents in highly comorbid patients who are poor operative candidates. Less invasive techniques, such as cryoablation and radiofrequency ablation, are effective, but require percutaneous or laparoscopic access, while generally being limited to cT1a tumors without proximity to the renal pelvis or ureter. Active surveillance is another management option for small renal masses, but many patients desire treatment or are poor candidates for active surveillance. For poor surgical candidates, a growing body of evidence supports stereotactic ablative radiotherapy (SABR) as a safe and effective non-invasive treatment modality. For example, a recent multi-institution individual patient data meta-analysis of 190 patients managed with SABR estimated a 5.5% five-year cumulative incidence of local failure with one patient experiencing grade 4 toxicity, and no other grade ≥3 toxic events. Here, we discuss the recent developments in SABR for the management of localized renal cell carcinoma, highlighting key concepts of appropriate patient selection, treatment design, treatment delivery, and response assessment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Cancers. - 15, 14 (2023) , 3672, ISSN: 2072-6694
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2023
- Creator
-
Barbour, Andrew B.
Kirste, Simon
Grosu, Anca-Ligia
Siva, Shankar
Louie, Alexander V.
Onishi, Hiroshi
Swaminath, Anand
Teh, Bin S.
Psutka, Sarah P.
Weg, Emily S.
Chen, Jonathan
Zeng, Jing
Gore, John L.
Hall, Evan
Liao, Jay J.
Correa, Rohann J. M.
Lo, Simon S.
- DOI
-
10.3390/cancers15143672
- URN
-
urn:nbn:de:bsz:25-freidok-2382043
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Barbour, Andrew B.
- Kirste, Simon
- Grosu, Anca-Ligia
- Siva, Shankar
- Louie, Alexander V.
- Onishi, Hiroshi
- Swaminath, Anand
- Teh, Bin S.
- Psutka, Sarah P.
- Weg, Emily S.
- Chen, Jonathan
- Zeng, Jing
- Gore, John L.
- Hall, Evan
- Liao, Jay J.
- Correa, Rohann J. M.
- Lo, Simon S.
- Universität
Time of origin
- 2023
Other Objects (12)
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen
Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms : = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie : = [10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]
Einfluss einer adjuvanten Strahlentherapie im Vergleich zur „Early-salvage-Strahlentherapie“ auf die Letalität von Männern mit einem hohen Rezidivrisiko nach radikaler Prostatektomie wegen Prostatakarzinom : = Influence of adjuvant vs early salvage radiotherapy on lethality in men with high risk for recurrence following radical prostatectomy for prostate cancer
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Target volume definition in radiation oncology
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen
Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms : = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie : = [10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]
Einfluss einer adjuvanten Strahlentherapie im Vergleich zur „Early-salvage-Strahlentherapie“ auf die Letalität von Männern mit einem hohen Rezidivrisiko nach radikaler Prostatektomie wegen Prostatakarzinom : = Influence of adjuvant vs early salvage radiotherapy on lethality in men with high risk for recurrence following radical prostatectomy for prostate cancer
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Target volume definition in radiation oncology
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen
Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms : = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie : = [10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]
Einfluss einer adjuvanten Strahlentherapie im Vergleich zur „Early-salvage-Strahlentherapie“ auf die Letalität von Männern mit einem hohen Rezidivrisiko nach radikaler Prostatektomie wegen Prostatakarzinom : = Influence of adjuvant vs early salvage radiotherapy on lethality in men with high risk for recurrence following radical prostatectomy for prostate cancer
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma